ESSURE ESS305

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a consumer,foreign,other report with the FDA on 2020-03-26 for ESSURE ESS305 manufactured by Bayer Pharma Ag.

Event Text Entries

[188664487] This case was initially received via regulatory authority ((b)(6), reference number: (b)(4)) on 24-mar-2020. This spontaneous case was reported by a consumer and describes the occurrence of back pain ('back pain') and eye haemorrhage ('problem with blood in left eye') in an adult female patient who had essure inserted. The occurrence of additional non-serious events is detailed below. On (b)(6) 2013, the patient had essure inserted. On (b)(6) 2013, the patient experienced back pain (seriousness criterion medically significant), eye haemorrhage (seriousness criterion medically significant), vision blurred ("problem with blurred left eye"), anosmia ("loss of smell"), anxiety ("anxiety attack at night"), insomnia ("insomnia"), vaginal discharge ("malodorous discharge"), depressed mood ("sadness"), haemorrhoids ("frequent haemorrhoids"), paraesthesia ("tingling in legs"), cardiovascular disorder ("circulation problem"), limb discomfort ("streaky legs"), nasal obstruction ("continuously blocked nose"), neck pain ("neck pain"), burning sensation ("burning sensations"), abdominal distension ("continuous abdominal swelling"), diarrhoea ("diarrhoea at night"), arthralgia ("ankle and joint pain") and headache ("headaches"). At the time of the report, the back pain, eye haemorrhage, vision blurred, anosmia, anxiety, insomnia, vaginal discharge, depressed mood, haemorrhoids, paraesthesia, cardiovascular disorder, limb discomfort, nasal obstruction, neck pain, burning sensation, abdominal distension, diarrhoea, arthralgia and headache outcome was unknown. The reporter considered abdominal distension, anosmia, anxiety, arthralgia, back pain, burning sensation, cardiovascular disorder, depressed mood, diarrhoea, eye haemorrhage, haemorrhoids, headache, insomnia, limb discomfort, nasal obstruction, neck pain, paraesthesia, vaginal discharge and vision blurred to be related to essure. The reporter commented: i have discovered that all my symptoms are due to my essure thanks to the resist website. I had never made the connection that my daily suffering was due to this horror. Based on the available information, a review of our complaint records and other relevant data will be conducted; any new and reportable information that becomes available from our investigation will be provided in a supplementary report.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2951250-2020-02744
MDR Report Key9883220
Report SourceCONSUMER,FOREIGN,OTHER
Date Received2020-03-26
Date of Report2020-04-01
Date of Event2013-09-24
Date Mfgr Received2020-03-24
Date Added to Maude2020-03-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactK SHAW LAMBERSON
Manufacturer Street100 BAYER BLVD, P.O. BOX 915
Manufacturer CityWHIPPANY NJ 07981
Manufacturer CountryUS
Manufacturer Postal07981
Manufacturer G1BAYER PHARMA AG
Manufacturer StreetM
Manufacturer CityBERLIN, 13353
Manufacturer CountryGM
Manufacturer Postal Code13353
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameESSURE
Generic NameTRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Product CodeHHS
Date Received2020-03-26
Model NumberESS305
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBAYER PHARMA AG
Manufacturer AddressM?LLERSTR. 178 BERLIN, 13353 GM 13353


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2020-03-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.